35 related articles for article (PubMed ID: 27601079)
1. Eyelid basal cell carcinoma treated with Imiquimod 5% cream monotherapy.
Singh M; Kaur M
Orbit; 2023 Jan; ():1. PubMed ID: 36661034
[No Abstract] [Full Text] [Related]
2. Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.
Karabulut GO; Kaynak P; Ozturker C; Fazil K; Ocak OB; Taskapılı M
Indian J Ophthalmol; 2017 Jan; 65(1):48-51. PubMed ID: 28300740
[TBL] [Abstract][Full Text] [Related]
3. The use of imiquimod in the treatment of periocular tumours.
Ross AH; Kennedy CT; Collins C; Harrad RA
Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545
[TBL] [Abstract][Full Text] [Related]
4. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study.
Choontanom R; Thanos S; Busse H; Stupp T
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1217-20. PubMed ID: 17345092
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Blasi MA; Giammaria D; Balestrazzi E
Am J Ophthalmol; 2005 Dec; 140(6):1136-9. PubMed ID: 16376667
[TBL] [Abstract][Full Text] [Related]
6. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
Garcia-Martin E; Gil-Arribas LM; Idoipe M; Alfaro J; Pueyo V; Pablo LE; Fernandez FJ
Br J Ophthalmol; 2011 Oct; 95(10):1393-6. PubMed ID: 21242584
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Garcia-Martin E; Idoipe M; Gil LM; Pueyo V; Alfaro J; Pablo LE; Zubiri ML; Fernandez J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):373-9. PubMed ID: 20698800
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication.
Costales-Álvarez C; Álvarez-Coronado M; Rozas-Reyes P; González-Rodríguez CM; Fernández-Vega L
Arch Soc Esp Oftalmol; 2017 Feb; 92(2):93-96. PubMed ID: 27601079
[TBL] [Abstract][Full Text] [Related]
9. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
Wagstaff AJ; Perry CM
Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
Sapijaszko MJ
Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
12. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Sriprakash K; Godbolt A
Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]